The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders
Condition(s):Poor RespondersLast Updated:July 18, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Poor RespondersLast Updated:July 18, 2023Not yet recruiting
Condition(s):InfertilityLast Updated:May 7, 2014Completed
Condition(s):Vaginal AtrophyLast Updated:June 26, 2017Completed
Condition(s):Chronic Obstructive Pulmonary Disease; Hypertension, PulmonaryLast Updated:January 14, 2015Unknown status
Condition(s):Skin AtrophyLast Updated:December 21, 2018Unknown status
Condition(s):Infertility; Ovarian Aging; Diminished Ovarian Reserve (DOR); Predicted Poor-respondersLast Updated:December 9, 2015Completed
Condition(s):Hypoactive Sexual Desire DisorderLast Updated:December 1, 2009Unknown status
Condition(s):Chronic Obstructive Pulmonary Disease; Hypertension, PulmonaryLast Updated:February 9, 2022Completed
Condition(s):Breast CancerLast Updated:September 17, 2019Terminated
Condition(s):Infertility; Decreased Ovarian ReserveLast Updated:April 2, 2008Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.